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doi:10.1016/j.ejvs.2011.01.020Abstract Objectives: The aim of this study was to evaluate patients, who underwent spiral
vein reconstruction of the abdominal aorta to repair infected aneurysms or replace infected
aortic grafts.
Methods: All spiral vein reconstructions between March 2005 and May 2010 because of vascular
infections of the abdominal aorta were retrospectively included. Diagnosis was determined by
clinical examination, laboratory results, computed tomography (CT) and positron emission
tomography (PET) scan, and microbiological tests. Spiral vein reconstruction consisted of har-
vesting the greater saphenous vein (GSV) and construction into a spiral graft, aortic recon-
struction and a transmesenteric omentumplasty. Primary outcomes were survival and limb
salvage. Secondary outcomes included technical, clinical and ongoing success, re-infection,
ongoing infection and patency.
Results: All five patients survived surgery, and there were no in-hospital deaths. Survival and
limb salvage were 100% after median follow-up of 13 months (6e67 months). Further, tech-
nical, clinical and continuing success was 100%. There were no re-infections or ongoing infec-
tions.
Conclusions: Spiral vein reconstruction using the GSV showed good short-term survival and
limb salvage. It, therefore, might be considered as an attractive treatment method for
vascular infections of the abdominal aorta. Still, more follow-up is needed to evaluate
long-term results.
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Figure 1 Construction of the spiral vein graft.
638 M. van Zitteren et al.Infected grafts (1e6%) and infected aneurysms (<1%) of the
abdominal aorta are rare.1 They remain serious conditions
associated with high morbidity and mortality (25e88%),2
and create reconstructive challenges to vascular surgeons.
Standard treatment includes aneurysm resection, extensive
debridement, aortic reconstruction and long-term antibi-
otic treatment.3 Reconstruction of the abdominal aorta
using synthetic grafts is associated with poor survival.4 In
situ reconstruction with autologous veins or cryopreserved
arterial homografts (CAHs) can potentially eradicate
infection and preserve arterial continuity.5,6 Several
studies have proposed the use of the femoral vein as an
arterial substitute in vascular infections.4,7e10 The spiral
vein technique was first described by Chiu et al. in a series
of 13 dogs in 1974,11 and attempted in humans with
a superior vena cava syndrome by Doty et al. in 1976.12
Venous lesions have been successfully treated since.13
However, this technique has been described to a limited
extent for aortic reconstructions.14,15
We described the first case of a successfully treated,
ruptured, infected aneurysm using the greater saphenous
vein (GSV) for spiral vein reconstruction in our hospital in
2006.15 Since then, we treated five patients using this
technique. This study describes our experience with the
spiral vein reconstruction using the GSV for infected
abdominal aortic aneurysms and aortic grafts.
Methods
Patients
Patients, treated for infection of the abdominal aorta using
the GSV to create a spiral vein graft between March 2005
and May 2010, are included. Infection is defined as having
(1) clinical symptoms suggestive for infection, with a posi-
tive or negative Gram stain and/or blood culture, or (2)
a proven infection by a positive culture and/or Gram stain
from blood, the aneurysm wall, graft or periaortic fluids or
tissues, and where specific microorganisms are reported.16
Primary outcomes are survival (in-hospital, 6 months, 2 and
5 years) and limb salvage. Secondary outcomes are feasi-
bility of the procedure, re-infection and patency. Data are
retrospectively collected by reviewing patient records. The
local ethics committee is informed and it approved the
spiral vein technique. Informed consent is provided
regarding the use of pictures from the surgical procedure.
Diagnostic work-up
Diagnostic evaluation is performed, if a vascular infection is
suspected after clinical examination. Infection parameters
are checked (e.g., C-reactive protein (CRP), erythrocyte
sedimentation rate, white blood cell count and blood
cultures). A computed tomography (CT) scan is performed
to determine signs of infection (e.g., perigraft fluid or soft-
tissue attenuation, ectopic gas, pseudo-aneurysm, focal
bowel wall thickening, intragraft thrombus and hydro-
nephrosis).17 A fluorodeoxyglucose (18F) positron emission
tomography (FDG-PET) scan is done to confirm diagnosis of
infection. A CT-guided fine-needle aspiration is performed.
Antibiotics are given according to microbiological tests.Vein status is evaluated in both legs by duplex ultrasound.
Finally, open reconstructive surgery is planned, and pieces
taken from the aneurysm wall, prosthetic graft or peri-
aortic tissues are cultured to confirm the causing pathogen
and adjust antibiotic strategies when necessary.
Spiral vein reconstruction
The spiral vein technique for reconstruction of the
abdominal aorta includes several steps. The total length of
the GSV that is needed to obtain a suitably fitting spiral
graft (i.e., no discrepancy in diameter and length) is
calculated by using the formula 2pr. Presume that the GSV
has a diameter of 3.3 mm, and a graft length of 10 cm and
15 mm in diameter is required. The outline of the GSV will
be 1 cm (2p  (0.033/2)) and the length needed to fit one
turn on a 15-mm diameter tube will be 4.7 cm (2p  (0.150/
2)). Subsequently, the total length of the GSV that is
needed to construct a spiral graft will be 47 cm ((total tube
length/the outline of the GSV)  the GSV length needed for
one turn Z (10/1)  4.7). The surgical procedure starts by
harvesting the GSV using several small incisions. Side-
branches are ligated using vicryl 4/0. Wounds are closed
primarily by continuous sutures. Next, the GSV is flushed
with heparinised blood. Leakages are sutured with Vascufil
6/0. Then, the GSV is cut open longitudinally over its full
length and tightly placed on a 15-mm diameter tube to
construct a suitably fitting graft, using continuous sutures
(Vascufil 6/0) with 1-mm intervals (Fig. 1). This procedure
has been previously described by Heikens et al.15 Median
laparotomy is performed simultaneously. Intravenous
heparin (2500e5000 units) is given before clamping the
aorta. The infected graft or aneurysm sac is opened,
flushed with heparinised water and excised, followed
by extensive debridement of the infectious mass on which
bacteriological tests are performed. The spiral vein is
then used to reconstruct the aorta using a standard inlay
technique (Fig. 2). End-to-end anastomoses are con-
structed using continuous sutures (Vascufil 4/0). Finally,
the neo-aorta is protected by coverage of a trans-
mesenteric omentumplasty that is fixated using several
vicryl 3/0 stitches (Fig. 3). Intravenous antibiotics are given
Figure 2 Reconstruction of the abdominal aorta.
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microbiological findings.
Postoperative management and follow-up
All patients are postoperatively monitored at the intensive
care unit (ICU). Antibiotics (intravenous) and anticoagu-
lants are continued during hospitalisation. Antibiotics are
switched to oral administration before discharge and
continued for several months. The type and dose depend on
microbiological findings (e.g., microorganism and sensi-
tivity). CT scans are performed before discharge. Routine
outpatient follow-up at about 1 week, 3 and 6 months afterFigure 3 Trans mesenteric omentumplasty.discharge includes clinical examinations, laboratory
assessments and contrast-enhanced CT scans to monitor
signs of infection, graft patency and to exclude spiral vein
dilatation. Follow-up is extended to annual visits, unless
more frequent visits are necessary.
Feasibility
Technical success18 is defined as proper construction and
placement of the spiral vein, without death and must be
maintained for at least 30 days postoperatively, and
comprises the following: (1) successful harvest of the GSV;
(2) successful construction of the spiral vein; (3) successful
reconstruction of the abdominal aorta, with no signs of
leakage after reconstruction; and (4) no signs of graft
failure on contrast-enhanced CT follow-up, such as graft
obstruction, thrombosis, dilatation (>20%) or degeneration
of the aneurysm at both anastomoses.
Clinical and continuing success
Clinical success18 is defined as having no signs of infection,
re-infection or ongoing infection at clinical examinations,
laboratory results or CT scans. Re-infection is defined as
recurrent infection after a period without infection.
Ongoing infection is defined as continuing infection with no
period wherein infection was absent. Continuing success
comprises both technical and clinical success.18 Duration of
successful outcomes is defined as short-term (6 months),
mid-term (2 years) and long-term (over 5 years).
Statistical methods
Due to the descriptive design of the study, only (summary)
descriptive statistics are considered to evaluate outcomes.
Therefore, no comparative tests yielding p-values are
used.
Results
Patients
Six patients were diagnosed with an infection of the
abdominal aorta and treated by spiral vein reconstruction
between March 2005 and May 2010. One was excluded
because a composite vein graft was used. Five patients
(three men) remained eligible for inclusion (three infected
grafts and two infected aneurysms). Clinical presentation
is presented in Table 1. Median age was 72 years
(70e78 years). Three patients previously underwent an
endovascular aneurysm repair (EVAR) procedure, with
a median time interval of 58 months (23e63 months) until
spiral vein reconstruction. Two underwent another proce-
dure between EVAR and spiral vein surgery. One had
a percutaneous transluminal angioplasty (PTA) due to renal
artery stenosis. The other underwent open repair of a small
type 1a and type 2 endoleak 3 weeks prior to the spiral vein
reconstruction. This patient was re-admitted due to rectal
blood loss and hypotension caused by a transverse colon
fistula after the endoleak repair. Cardiovascular co-
morbidity was present in all cases (Table 1).
Table 1 Patient demographics, clinical presentation and medical history.
Case no. Age
(years)
Sex Clinical Presentation Diagnosis Comorbidities & prior
surgery
Prior
procedure
Interval prior
procedure to
spiral vein
reconstruction
(months)
Operations between
prior procedure and
spiral vein
reconstruction
1 78 Female Abdominal and back pain,
nausea, transpiration,
post-prandial pain
Infected AAA þ
aorta-duodenal fistula
CABG, myocardial
infarction, COPD Gold III,
hypercholesterolemia
No e No
2 70 Female Abdominal and back pain,
fatigue, nausea, abdominal
pulsatile mass
Infected AAA þ leakage Hypertension, polycystic
kidneys, liver cysts,
pneumonia
No e No
3 71 Male Abdominal pain, cold
shivering, anorexia
Infected prosthetic graft Atrial fibrillation, PTCA,
TIA, hypertension (renal
artery stenosis), COPD
Gold III, cholecystectomy,
Type 2 diabetes mellitus
EVAR
(Talent)
23 PTA renal artery
(failed)
4 72 Male Abdominal and back pain,
rectal blood loss,
hypotension, dizziness
Infected prosthetic graft þ
transverse colon fistula
Type 1a and Type 2
endoleak, stable angina,
hypercholesterolemia,
hiatus hernia oesophagei
EVAR
(Excluder)
58 Median laparotomy
due to exploration
of the aneurysm sac
(small Type 1a and
Type 2 endoleak),
three weeks prior
to spiral vein
reconstruction
5 77 Male Malaise, fever, dyspnea
and dry chough
Infected prosthetic graft CABG, hypertension, Type 2
diabetes mellitus, pleuritis,
choledocholithiasis, basal
cell carcinoma head,
Bilroth I operation
EVAR
(Zenith)
63 No
Abbreviations: AAA Z aortic abdominal aneurysm, CABG Z coronary artery bypass graft, COPD Z chronic obstructive pulmonary disease, EVAR Z endovascular aneurysm repair, PT(C)
A Z percutaneous transluminal (coronary) angioplasty, TIA Z transient ischemic attack.
640
M
.
va
n
Z
itte
re
n
e
t
a
l.
Spiral Vein Reconstruction of the Infected Abdominal Aorta Using the Greater Saphenous Vein 641Diagnostic work up
Infection was suspected based on clinical signs (Table 1)
and demonstrated by diagnostic work-up (Table 2). Infec-
tion parameters were elevated for at least one parameter
(n Z 5), but none had a positive blood culture (n Z 4).
CT-findings were suggestive for infection in all cases and
signs of rupture were seen in two cases. Two had fine-
needle aspirations and two had a PET-scan, confirming
diagnosis. Duplex examinations were performed in elective
cases. Infections were caused by several microorganisms,
where Listeria monocytogenes was present in one case
(Table 2).
Surgical procedure
Two emergency reconstructions were performed. Based on
patients’ medical history, it was assumed that the GSV was
present in both cases. The GSV was harvested using a vein
stripper in one case. Preoperative duplex examinations
were performed in elective settings. The left GSV was
harvested in all cases. It was feasible to construct spiral
vein tubes with a diameter of 15 mm and a median length of
10 cm (6.5e11 cm), which is sufficient for reconstruction of
the abdominal aorta. Length and diameter of the spiral vein
reconstruction can be adjusted according to need. Median
laparotomy was performed. The aorta was clamped
infrarenal in four cases, but could not be clamped in one
case. Therefore, a balloon catheter was inflated supra-
renally. Both common iliac arteries were clamped in all
cases. Intravenous heparin was given prior to clamping.
Intraoperative bacteriological cultures were performed
after excision and debridement (Table 2). A trans-
mesenteric omentumplasty was constructed in all patients.
Fasciotomy was needed in one emergency case because of
a compartment syndrome of the left lower leg. Median
peroperative blood loss was 2500 ml (2000e5500 ml) and
median duration of surgery was 318 min (243e335 min). All
patients received intravenous antibiotics intra-operatively
(Table 3).
Postoperative management and follow-up
All patients survived surgery and there were no in-hospital
deaths (in-hospital survival 100%). Median postoperative
stay at the ICU was 6 days (1e54 days). One case was
complicated by several re-operations due to an abdominal
compartment syndrome, ischemic colon and tracheotomy.
Another had a re-operation 8 days later due to an abdom-
inal abscess. Intravenous antibiotics were given to all
patients postoperatively, according to intra-operative
microbiological findings. These were switched to oral
administration before discharge and continued for 3 weeks
to 10 months. Anticoagulants (thrombocyte aggregation
inhibitors) were continued postoperatively. Median post-
operative in-hospital stay was 34 days (20e70 days). Two
patients were re-admitted due to general malaise 9 and 16
days after discharge, where signs of infection were evalu-
ated. One was carefully monitored, while the other
received antibiotics due to faeces cultures that were
positive for Clostridium. Median follow-up was 13 months((6e67 months, short term n Z 3), mid-term (n Z 1) and
long term (n Z 1)) (see Tables 4 and 5).
Technical, clinical and continuing success
Spiral vein reconstruction was technically possible in all
cases. There were no signs of graft failure and no deaths
occurred within 30 days postoperative (technical success
100%). None of the cases required elastic stockings after
GSV harvest during follow-up. Two patients had a small fluid
collection (one abscess) on postoperative CT scans that
resolved during follow-up. All patients survived during
follow-up (100% survival), and there were no limb ampu-
tations (100% limb salvage). Last follow-up showed no signs
suspected for ongoing infection or re-infection (clinical
success 100%), and there were no signs of graft failure
(Fig. 4) (patency and continuing success 100%). All results
reflect short-term (nZ 3), mid-term (nZ 1) and long-term
follow-up (n Z 1) (see Table 5).
Discussion
This study evaluates our experience with five patients, who
underwent a spiral vein reconstruction of the abdominal
aorta. The GSV is harvested, cut open longitudinally and
tightly placed on a 15-mm tube to construct a spiral graft
using continuous sutures. A standard inlay method is used
for aortic reconstruction, and the neo-aorta is protected by
a transmesenteric omentumplasty. All patients survived
surgery and there were no in-hospital deaths. Median
follow-up was 13 months (6e67 months). Survival and limb
salvage were 100% during follow-up, and technical, clinical
and continuing success were 100%. There were no re-
infections or ongoing infections and the spiral vein was
patent in all cases, showing no dilatation, although only one
has a long-term follow-up. Antibiotics were continued for 3
weeks to 10 months postoperatively, based on microbio-
logical findings to prevent any ongoing or re-infection.
This study is the first to evaluate preliminary results of
spiral vein reconstructions of the abdominal aorta using the
GSV. Continued follow-up and prospective inclusion of new
patients in future perspectives will enable long-term eval-
uation of this technique. The retrospective design, small
sample size and lack of mid- and long-term follow-up are
limitations of this study. Therefore, results should be
interpreted with caution, despite encouraging outcomes.
A diagnostic work-up approach, surgical procedure and
postoperative management are presented as treatment
algorithm, but could have limitations in emergency situa-
tions where (1) patients are unstable or (2) infection is
diagnosed intra-operatively. In these cases, a vein stripper
can be used to rapidly harvest the GSV.15 Lack of available
veins could occur in (3) patients with prior bypass surgery or
(4) mismatching of the spiral graft in emergency settings
(e.g., no prior duplex ultrasounds). Alternatively,
composite vein grafts or veins from the arms might be used.
However, in the emergency case with prior bypass surgery,
there was still enough GSV left to construct a spiral vein.
Finally, it is not recommended to harvest veins in patients
with (5) prior deep vein thrombosis or pulmonary embo-
lisms. Autologous deep veins, CAHs and silver-coated or
Table 2 Diagnostic work-up.
Case no. Infection
parameters
Blood
culture
CT-scan PET-scan CT-scan fine needle
aspiration culture
Duplex examination Intraoperative tissue
culture
1 CRP 9.8
Leukocytes 11.8
ESR 71
Hb 7.3
NA AAA 4.3 cm with
thrombus at the aneurysm
wall, several periaortic
lymph nodes,
aortoduodenal fistula
NA NA NA E. coli
2 Leukocytes 13.4
ESR 35
Hb 7.9
No growth AAA with extensive
plaques at the aneurysm
wall, hematoma at
aneurysm sac (rupture)
NA NA NA Prevotella species
3 CRP 242
Leukocytes 9.7
Hb 7.7
No growth Increase diameter
aneurysm, suggestive for
graft infection
Increased FDG
uptake at site of graft
and aneurysm wall
Coagulase negative
staphylococcus
Deep and superficial
system is open,
sufficient diameters
Listeria
monocytogenes
4 CRP 66
Leukocytes 12.2
Hb 5.5
No growth Enlarged aneurysm wall,
possible fistula, air bubble
in aneurysm, suggestive for
infection
NA NA Deep and superficial
system is open,
sufficient diameters
Proteus mirabilis,
E. coli
5 CRP 194
Leukocytes 6.6
Hb 6.9
No growth Increase fluid and tissues
at site of EVAR,
suggestive for infection
Increased FDG
activity at graft,
suspected for
infection
No growth Deep system with
wide diameters,
GSV bilaterally
narrow and absent
in right lower leg,
SSV narrow right
No microorganisms
Abbreviations: AAA Z aortic abdominal aneurysm, CRPZ C-Reactive Protein, ESR Z erythrocyte sedimentation rate, GSV Z greater aphenous vein, Hb Z hemoglobin, SSV Z smaller
saphenous vein, NA Z not available.
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Spiral Vein Reconstruction of the Infected Abdominal Aorta Using the Greater Saphenous Vein 643rifampicin-soaked grafts are alternatives in the aforemen-
tioned situations. The presented cases involve only
a straight aortic tube and not a bifurcated graft. However,
it is technically possible to construct a longer spiral tube as
an aorto-uni-iliac (with cross-over venous grafts) and
bifurcated spiral graft. Yet, these are not included in the
present study.
A CT- and FDG-PET-scan are performed in the diagnostic
work-up to assess signs of infection, but cannot reliably
determine if periaortic collections with increased FDG
uptake are inflamed or infected. A CT-guided fine-needle
aspiration of such collection can confirm diagnosis of
infection and determine the causing pathogen. Antibiotics
can be adjusted according to the antibiogram. The initial
CT-scan assesses the ideal biopsy site and patient position
to vascular structures and abdominal organs.19 The biopsy is
carefully performed. No bleeding complications were
encountered in this series.
Resection and drainage is mandatory in vascular infec-
tions. Aortic reconstruction can be performed using pros-
thetic grafts, extra-anatomic bypasses or in situ
reconstruction with CAH or autologous veins. Nevertheless,
re-infection seems a major disadvantage using prosthetic
replacements for infected conditions (5e25%).3 Disadvan-
tages of the extra-anatomic bypass include re-infection
(10e23%), mortality (20%), graft failure (35%) and limb
amputation (11%).3 Using CAH seems advantageous because
of resistance to infection and acceptable survival (81% 3-
year survival), but is limited due to degeneration, limited
availability and higher costs.5 Autologous venous recon-
struction is a favorable method as these veins are bilater-
ally available, satisfactory in length and diameter, can
withstand aortic pressure, have low risk of re-infection,
reduce risk of late graft rupture and minimise
mortality.4,20,21 We consider an adjunct omentumplasty,
however, as mandatory. Postoperatively, patients receive
long-term antibiotics, and could be stopped after 3 months.
Disadvantages include possible late degeneration.20
Patients should be subject to follow-up. Dilatation of the
spiral vein graft could be treated by EVAR.
In 2003, Daenens et al. showed their 10 -year experience
with autogenous aortic reconstructions using the femoral
vein for prosthetic infections in 49 patients.22 Their 5-year
survival rate was 60% (8% in-hospital deaths). Five-year limb
salvage and primary patency were 98% and 91%, respec-
tively. No re-infections occurred. The femoral vein is suit-
able as arterial substitute because of a relative thick wall
with an endothelial surface that makes it more resistant to
thrombosis, kinking and infections and shows good overall
patencies,22 though femoral vein harvest is a more surgical
demanding, time-consuming procedure6 and includes
higher risk of bleeding due to larger diameters of side
branches (3%, with 36% mortality), stenosis due to incom-
plete valvulotomy, risk of discrepancy in diameter (10%)
and graft revision (4.6%).20 Relative venous outflow
obstruction is seen in 75e93%,4,8,20e23 and 18e20% need
fasciotomy after total deep vein harvest.20,24 Despite this,
elevated venous pressure seems not to be func-
tional,4,8,20,22 while others report long-term leg oedema in
one-third and (asymptomatic) reflux (11e48%).20,21,24
There might be a discrepancy in diameter at the aortic
anastomosis, when using the femoral vein as arterial
Table 4 Postoperative management.
Case
no.
Re-operations Complications Stay ICU
(days)
In-hospital
stay (days)
Continuation
antibiotics
Postoperative
anticoagulants
1 Day 0 abdominal
compartment syndrome,
Day 2 ischemic
intestines, Day 9
closing abdomen,
Day 18 tracheotomy
Compartment
syndrome (abdominal
and left lower leg),
ischemic colon,
wound dehiscence
abdomen, yeast
infection (Candida),
wound infection groin
(Pseudomonas left site),
pulmonary oedema,
tracheotomy
54 70 Co-trimoxazole
(10 months)
Aspirin
2 No e 7 20 Amoxicillin
(6 months)
Aspirin
3 No Re-admission due
to general malaise:
general monitoring
1 34 Amoxicillin
(2.5 months)
Aspirin,
Clopidogrel
4 Day 8 abdominal
abscess
Ischemic colon,
peritonitis
6 43 Metronidazole
and Ciprofloxacin
(6 months)
Aspirin
5 No Pneumonia
Re-admission due to
general malaise:
Metronidazole and
Vancomycin because
of Clostridium in
faeces culture
1 24 Cefuroxime
(3 weeks)
Aspirin
644 M. van Zitteren et al.substitute. The spiral vein technique overcomes this
problem and the GSV is usable regardless of its diameter.
The femoral vein is usable in 80e95% of patients presenting
with an infrarenal aortic graft infection,20,22 while it is
always possible to use the GSV for spiral vein reconstruction
in this study. Another advantage of autologous veins is theTable 5 Follow-up.
Case
no.
Follow-up Outcom
Signs of
infectiona
Last CT-findings Monthsb Technic
success
1 No No signs of infection,
patent venous conduit
67 Yes
2 No No signs of infection,
patent venous conduit
31 Yes
3 No No signs of infection,
patent venous conduit
13 Yes
4 No No signs of infection,
patent venous conduit.
13 Yes
5 No Decrease small periaortic
fluid collection.
No signs of infection.
Patent venous conduit.
6 Yes
a Signs of infection at last follow-up, including re-infection and ong
b Until November 1st 2010.
c Short-term 6 months, mid-term 2 years, long-term 5 years.possibility to discontinue antibiotic administration, if signs
of infection stay absent.
Vascular infections are mostly caused by Staphylococcus
aureus, Salmonella and Streptococcus sp.25,26 L. mono-
cytogenes was found in one patient. This Gram-positive
pathogen is an uncommon, but serious, cause of vascularesc
al Clinical
success
Ongoing
successb
Limb
salvage
Patency Survival
Yes Yes Yes Yes Yes, long-term
survival
Yes Yes Yes Yes Yes, mid-term
survival
Yes Yes Yes Yes Yes, short-term
survival
Yes Yes Yes Yes Yes, short-term
survival
Yes Yes Yes Yes Yes, short-term
survival
oing infection.
Figure 4 Postoperative CT-scan with spiral vein in situ.
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the immunosuppressed and elderly.27 Yet, it seems to
become a more common pathogen as it is widespread
through our environment (5% of humans are asymptomatic
faecal carriers).25 The first case has been described in
196528 and only 24 cases of vascular infections caused by L.
monocytogenes have been reported worldwide until 2008.26
However, the bacteriological spectrum of primary infected
aorto-iliac aneurysms seems wider than previously reported
as L. monocytogenes is identified in four of 26 patients in
a single-center study.29 Three of these 26 patients were
treated with a venous conduit, two times using the femoral
vein and one patient was treated with a GSV femoroefe-
moral bypass. The in-hospital mortality was 23% overall.29
Conclusion
Standard surgical treatment for infected abdominal aortic
aneurysms or aortic grafts is undisputed and consists of
resection, extensive debridement, aortic reconstruction
and antibiotic administration. Spiral vein reconstruction
using the GSV shows a 100% survival, limb salvage, patency,
technical, clinical and ongoing success in this study. This
technique might be considered as an alternative for the use
of deep leg veins, CAH and silver-coated or rifampicin-
soaked grafts. Nevertheless, more studies and follow-up
are needed to evaluate long-term results.
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